Conferences

17
Apr

Genoskin at the European Mast Cell and Basophil Research Network meeting

Genoskin at the European Mast Cell and Basophil Research Network meeting in ToulouseAdvancing mast cell research through in vitro evaluation of mast cell responsesWe were thrilled to participate in the prestigious European Mast cell and Basophil Research Network (EMBRN) Conference, which took place in Genoskin’s hometown, Toulouse, France, from May 29-31, 2024. This event brought together prominent academic researchers, clinicians,
Read more
18
Mar

Genoskin at the World Vaccine Congress in DC!

Genoskin at the World Vaccine CongressAdvancing Vaccine Research with High-Dimensional Immune ProfilingFrom April 1-4, 2024, the global vaccine community gathered for the World Vaccine Congress in Washington, D.C. Taking place at the heart of the nation's capital, the congress was a cornerstone event for vaccine professionals worldwide, offering a platform for sharing groundbreaking research, fostering collaborations, and exploring the latest
Read more
15
Feb

Genoskin at SOT 63rd Annual Meeting and ToxExpo

Genoskin at SOT 63rd Annual Meeting and ToxExpoPioneering Human Skin Models for Advanced Toxicology ResearchAs the world of toxicology convened for the Society of Toxicology 63rd Annual Meeting and ToxExpo, Genoskin was excited to announce its participation in this event, which took place from March 10-14 at the Salt Palace Convention Center in Salt Lake City. This year, Genoskin showcased
Read more
14
Dec

Genoskin in Japan to attend 42th Annual JSID meeting

GENOSKIN TO ATTEND 42TH ANNUAL JSID MEETING Genoskin is very pleased to attend the 42th Annual Meeting of the Japanese Society for Investigative Dermatology (JSID). The meeting will take place in Kochi city, Japan from December 15th to 17th, 2017. The mission of the Japanese Society for Investigative Dermatology (JSID) is to advance the position of dermatology in the interdisciplinary world

Read more

29
Sep

Genoskin launches psoriasis skin model at ESDR-meeting

Toulouse, France, September 29th, 2017 – Genoskin launches a new skin model to study skin inflammation. InflammaSkin® is a T cell-driven skin inflammation model with a psoriasis-like phenotype. The pharmacological validation of this psoriasis skin model will be presented at the 47th annual ESDR meeting 2017 (Poster 100) on September 27th to 30th, 2017. Don't hesitate to visit us in booth #9. Why immunocompetent skin
Read more
13
Sep

Genoskin kicks off fundraising campaign

Genoskin kicks off fundraising campaign at CCI FINDays The Genoskin team is now officially ready to launch its biggest fundraising campaign so far, which aims to finance our international expansion. Pascal Descargues, our CEO, is heading for Paris next week to attend the CCI FINDays, the first in a series of fundraising meetings. CCI FINDays is a French event designed to help small and start-up
Read more